about
A new family with the mitochondrial tRNAGLU gene mutation m.14709T>C presenting with hydrops fetalis.The tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapy.Anti-angiogenic agents and cancer: current insights and future perspectives.Role of cytokines and chemokines in idiopathic inflammatory myopathies.Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy.The EuroMyositis registry: an international collaborative tool to facilitate myositis research.Activation of osmolyte pathways in inflammatory myopathy and Duchenne muscular dystrophy points to osmoregulation as a contributing pathogenic mechanism.Unraveling the mechanisms behind the enhanced MTT conversion by irradiated breast cancer cells.Beta-chemokine receptor expression in idiopathic inflammatory myopathies.Analysis of the whole mitochondrial genome: translation of the Ion Torrent Personal Genome Machine system to the diagnostic bench?A Critical Assessment of the Therapeutic Potential of Resveratrol Supplements for Treating Mitochondrial Disorders.How long noncoding RNAs enforce their will on mitochondrial activity: regulation of mitochondrial respiration, reactive oxygen species production, apoptosis, and metabolic reprogramming in cancer.New insights into the phenotype of FARS2 deficiency.Localization of the alpha-chemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathies.Nanoscopic X-ray fluorescence imaging and quantification of intracellular key-elements in cryofrozen Friedreich's ataxia fibroblasts.EXPRESS: Near-Infrared Spectroscopy Screening to Allow Detection of Pathogenic Mitochondrial DNA Variants in Subjects with Unexplained Abnormal Fatigue: A Preliminary Study.Increased angiotensin II type-2 receptor density in hyperplasia, DCIS and invasive carcinoma of the breast is paralleled with increased iNOS expression.Properties of the ventricular adrenergic signal transduction system during ontogeny of spontaneous hypertension in rats.Subcomplexes of mitochondrial complex V reveal mutations in mitochondrial DNA.Histochemical methods for the diagnosis of mitochondrial diseases.Lactic acidosis in a newborn with adrenal calcifications.The nonnecrotic invaded muscle fibers of polymyositis and sporadic inclusion body myositis: on the interplay of chemokines and stress proteins.Upregulation of chemokines and their receptors in Duchenne muscular dystrophy: potential for attenuation of myofiber necrosis.The multifaceted character of lymphotoxin β in inflammatory myopathies and muscular dystrophies.Localization and Expression of Nuclear Factor of Activated T-Cells 5 in Myoblasts Exposed to Pro-inflammatory Cytokines or Hyperosmolar Stress and in Biopsies from Myositis Patients.Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with ExtrasMyo-Inositol Transporter SLC5A3 Associates with Degenerative Changes and Inflammation in Sporadic Inclusion Body MyositisHow mitochondrial DNA-driven changes to chromosomal DNA methylation add a layer of complexity to mitochondrial diseaseRelevance of solute carrier family 5 transporter defects to inherited and acquired human diseaseIdiopathic inflammatory myopathy: Interrater variability in muscle biopsy readingThe myokine GDF-15 is a potential biomarker for myositis and associates with the protein aggregates of sporadic inclusion body myositis
P50
Q31084743-54B25FC7-A38D-4EEC-AA44-88F2054120A3Q35450066-B3EEFD03-182B-48BF-9876-36FC8B0EC0D2Q37516219-30196421-C423-4727-8098-A5C446948628Q37591130-5309E3A1-78BA-4511-BA31-B8AEE882D3C2Q38168509-42FC0D78-D49D-45AD-B9E6-629F0C315558Q38601741-151A4986-F47F-417B-B444-BAB116ED02E8Q38763290-32D9A38D-8A93-46E2-8BFC-F97B5C739A9DQ39184778-4CF2A1F8-901B-44A0-A87C-FF7716145A6FQ40437459-ECCF97D5-1BB1-4B1D-AA74-9AEDDB30858BQ41999133-528EBEF4-2C9B-4954-8D17-B7340EFBD197Q42175132-27E81B01-4635-48D8-8136-DB7A7834B58AQ46311008-B819AF43-2A4C-4189-9B33-F427CF63BB08Q47149710-8BA725FA-E7BD-4128-9D1A-ED09E3074E9EQ47955065-4DF90B70-B4A6-423A-A4C0-4F358C1BC71DQ48226708-63692C58-4989-48FB-A35D-58FE5C5EE5CAQ49032812-495326B8-4A7A-4C20-B2E8-F8905C1C4DEEQ49052105-315284C0-70D5-420C-9ECA-EFC85E40F07FQ49077976-B15BF96D-A7D5-470B-8CC7-DB9F0E64A2F6Q49121755-4F6F20CC-D38E-4D76-BC58-3B1A87B39209Q49123647-69FCBB6F-2C5D-49E6-A47E-BA14B3DDF640Q49130561-B0B275DC-DE66-427A-BE8F-CF90ACF9D40EQ49140826-3D83E406-BB18-4A81-BEE1-07DE5A42D211Q49144546-B89175AC-C6F4-4322-8F90-77719DE3EEE5Q49161666-EA79C47A-5279-43E7-821D-44AB682F8027Q55438831-B916EEC1-EA96-47BF-9CA7-1C6D9EAD1B64Q61803937-429E948C-C975-4739-B7D2-340D4F2F12FCQ90809789-EC0198DC-EB11-4F0F-BE2E-D9628DA83EBBQ91393821-1DC2F3D0-DB1A-43BD-BA37-1FAEB95E2118Q91730295-87B2A6DA-B760-4466-A720-1284D0D154C7Q92264630-75F9ACD6-E1C4-40A2-8593-B9097C6E9AC4Q92416014-9B3EEEB1-3E7D-480C-9E92-8A2CCA323D2B
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Boel De Paepe
@ast
Boel De Paepe
@en
Boel De Paepe
@es
Boel De Paepe
@fr
Boel De Paepe
@nl
Boel De Paepe
@sl
type
label
Boel De Paepe
@ast
Boel De Paepe
@en
Boel De Paepe
@es
Boel De Paepe
@fr
Boel De Paepe
@nl
Boel De Paepe
@sl
prefLabel
Boel De Paepe
@ast
Boel De Paepe
@en
Boel De Paepe
@es
Boel De Paepe
@fr
Boel De Paepe
@nl
Boel De Paepe
@sl
P1053
B-7548-2013
P106
P2038
Boel_Paepe
P21
P31
P3829
P496
0000-0001-9403-4401